Explaining racial differences in prostate cancer in the United States: Sociology or biology?

被引:108
作者
Freedland, SJ [1 ]
Isaacs, WB [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Urol, Brady Urol Inst, Baltimore, MD 21287 USA
关键词
prostate cancer; race; socioeconomic; genetic;
D O I
10.1002/pros.20052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Black men in the United States have the highest incidence and mortality from prostate cancer in the world. Even after adjusting for stage It diagnosis, black men have higher mortality rates than white men. Multiple reasons have been postulated to explain these findings including access to care, attitudes about care, socioeconomic and education differences, differences in type and aggressiveness of treatment, dietary, and genetic differences. While each reason may contribute to the higher incidence or higher mortality, likely combinations of reasons will best explain all the findings. Racial differences in socioeconomic status have been well established and we review the significance of these findings in relationship to prostate cancer. Also, with recent advances in the understanding of genetic variation in the human genome, in general, and in the genes involved in pathways relevant to prostate cancer biology in particular, a number of genes with alleles which differ in frequency between black and white men have been proposed as a genetic cause or contributor to the increased prostate cancer risk in black men. However, the clinical significance of these genetic differences is not fully known. Finally, we conclude with some thoughts as to how to integrate the findings from sociological as well as biological studies and touch upon methods to reduce the disparate burden of prostate cancer among blacks in the United States. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:243 / 252
页数:10
相关论文
共 126 条
  • [71] The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white?
    Lentsch, AB
    [J]. FASEB JOURNAL, 2002, 16 (09) : 1093 - 1095
  • [72] Nutrient intake over time in a multi-ethnic sample of youth
    Lytle, LA
    Himes, JH
    Feldman, H
    Zive, M
    Dwyer, J
    Hoelscher, D
    Webber, L
    Yang, MH
    [J]. PUBLIC HEALTH NUTRITION, 2002, 5 (02) : 319 - 328
  • [73] Hormonal, cellular, and molecular control of prostatic development
    Marker, PC
    Donjacour, AA
    Dahiya, R
    Cunha, GR
    [J]. DEVELOPMENTAL BIOLOGY, 2003, 253 (02) : 165 - 174
  • [74] Nonaggressive management of white and Black prostate cancer patients in the United States
    Merrill, RM
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (02) : 94 - 99
  • [75] Explaining the difference in prostate cancer mortality rates between white and black men in the United States
    Merrill, RM
    Lyon, JL
    [J]. UROLOGY, 2000, 55 (05) : 730 - 735
  • [76] Papa Schaeg on economic reform in Russia
    Millar, JR
    [J]. PROBLEMS OF POST-COMMUNISM, 2001, 48 (03) : 3 - 9
  • [77] The continuing epidemic of obesity in the United States
    Mokdad, AH
    Serdula, MK
    Dietz, WH
    Bowman, BA
    Marks, JS
    Koplan, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (13): : 1650 - 1651
  • [78] Age-specific reference ranges for serum prostate-specific antigen in black men
    Morgan, TO
    Jacobsen, SJ
    McCarthy, WF
    Jacobson, DJ
    McLeod, DG
    Moul, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (05) : 304 - 310
  • [79] Screening for prostate cancer in african americans
    Moul J.W.
    [J]. Current Urology Reports, 2000, 1 (1) : 57 - 64
  • [80] Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the center for prostate disease research and cancer of the prostate strategic urologic research endeavor databases
    Moul, JW
    Connelly, RR
    Lubeck, DP
    Bauer, JJ
    Sun, L
    Flanders, SC
    Grossfeld, GD
    Carroll, PR
    [J]. JOURNAL OF UROLOGY, 2001, 166 (04) : 1322 - 1327